{"component": "definition", "props": {"groups": [{"snippet": "means transplantation between genetically non-identical individuals of the same species.", "samples": [{"hash": "hvSVJ95PD62", "uri": "https://www.michigan.gov/-/media/Project/Websites/mdhhs/Folder2/Folder24/Folder1/Folder124/DRAFT_CON-229_CON_Rev_Stds_BMT_FOR_CON_MTG_3_16_17.pdf?rev=55130b603a39409fb1e3202335d15d2a", "label": "www.michigan.gov", "score": 8.5906913073, "published": false}, {"hash": "eHc7zSRKgJM", "uri": "https://www.michigan.gov/documents/mdch/CON-229_CON_Rev_Stds_BMT_03.22.13_415387_7.pdf", "label": "www.michigan.gov", "score": 7.3709787817, "published": false}, {"hash": "hW7jgK4u7GC", "uri": "https://www.michigan.gov/-/media/Project/Websites/mdhhs/Folder2/Folder22/Folder1/Folder122/APPROVED_Commission_Min_31617.pdf?rev=4e215aa35b024624baae1a612af352c5", "label": "www.michigan.gov", "score": 6.7371663244, "published": false}], "size": 3, "snippet_links": [], "hash": "53c81a5f85bf235172eeed3eb956a0a6", "id": 1}, {"snippet": "means the treatment of a patient with human cells derived from a donor other than the patient, where such donor is genetically non-identical. \u201cAllogeneic\u201d does not include the treatment of a patient with human cells derived from such patient\u2019s own cells (autologous treatment).", "samples": [{"hash": "k0sdhUE1UCf", "uri": "/contracts/k0sdhUE1UCf#allogeneic", "label": "Development and Commercial License Agreement (Precision Biosciences Inc)", "score": 30.1937029432, "published": true}, {"hash": "4naiH06NA7C", "uri": "/contracts/4naiH06NA7C#allogeneic", "label": "Development and Commercial License Agreement (Precision Biosciences Inc)", "score": 29.9883641342, "published": true}, {"hash": "lOx0UotXCM4", "uri": "https://investor.precisionbiosciences.com/static-files/69ceadc2-96b0-4994-8bc1-9d23bd31f745", "label": "Amendment", "score": 14.1704312115, "published": false}], "size": 3, "snippet_links": [{"key": "treatment-of", "type": "definition", "offset": [10, 22]}], "hash": "2ff37a1912560218f8ba25969ccc27b3", "id": 2}, {"snippet": "means for use by another individual;", "samples": [{"hash": "fMpRsCMjr3", "uri": "/contracts/fMpRsCMjr3#allogeneic", "label": "Cord Blood/Tissue Banking and Related Services Agreement", "score": 24.6386036961, "published": true}, {"hash": "9jNVvSypzrX", "uri": "/contracts/9jNVvSypzrX#allogeneic", "label": "Cord Blood/Tissue Banking and Related Services Agreement", "score": 24.6235455168, "published": true}], "size": 2, "snippet_links": [], "hash": "5b996e91a1ea13454a821305b39ea3ae", "id": 3}, {"snippet": "does not include the treatment of a patient with human cells derived from such patient\u2019s own cells (autologous treatment).", "samples": [{"hash": "k0sdhUE1UCf", "uri": "/contracts/k0sdhUE1UCf#allogeneic", "label": "Development and Commercial License Agreement (Precision Biosciences Inc)", "score": 30.1937029432, "published": true}, {"hash": "4naiH06NA7C", "uri": "/contracts/4naiH06NA7C#allogeneic", "label": "Development and Commercial License Agreement (Precision Biosciences Inc)", "score": 29.9883641342, "published": true}], "size": 2, "snippet_links": [{"key": "treatment-of", "type": "definition", "offset": [21, 33]}], "hash": "7a479b5dc2044f4a6f928c3718fa902f", "id": 4}, {"snippet": "means transplantation between genetically nonidentical individuals of the same species.", "samples": [{"hash": "jr59NEzZcQf", "uri": "https://www.michigan.gov/-/media/Project/Websites/mdhhs/Folder1/Folder64/BMT_Standards.pdf?rev=1596dd42c97f46859c32e41581e80378", "label": "www.michigan.gov", "score": 5.2012320329, "published": false}, {"hash": "k9JWaoM3ACv", "uri": "https://www.michigan.gov/documents/CON-229_CON_Rev_Stds_Bone_Marrow_Transplantation_Svcs_6-4-04_93547_7.pdf", "label": "www.michigan.gov", "score": 5.0, "published": false}], "size": 2, "snippet_links": [], "hash": "7d3ba2d1f7824209051e79b19b577d73", "id": 5}, {"snippet": "the term \u2018allo-\u2019 means \u2018other\u2019. An allogeneic stem cell transplantation involves the transfer of stem cells from a healthy donor to a patient who has received ablative or conditioning treatment. Special tests are done to see if a donor\u2019s stem cells are a good match for a recipient. A brother or sister is most likely to be a good match. Sometimes parents, children, and other relatives are good matches. Unrelated donors who are not related to the recipient, yet still match, may be found through national bone marrow registries", "samples": [{"hash": "96eBUWnnMSD", "uri": "https://hemogenyx.com/wp-content/uploads/2021/01/Hemogenyx_Pharmaceuticals_Prospectus_20200129.pdf", "label": "Subscription Agreement", "score": 14.5386721424, "published": false}, {"hash": "kQNECzEYeus", "uri": "https://hemogenyx.com/wp-content/uploads/2020/12/Circular_Hemogenyx_Pharmaceuticals_general_meeting_20201218.pdf", "label": "hemogenyx.com", "score": 8.9288158795, "published": false}], "size": 2, "snippet_links": [{"key": "the-term", "type": "definition", "offset": [0, 8]}, {"key": "transfer-of", "type": "definition", "offset": [85, 96]}, {"key": "stem-cells", "type": "definition", "offset": [97, 107]}, {"key": "special-tests", "type": "clause", "offset": [195, 208]}, {"key": "brother-or-sister", "type": "definition", "offset": [285, 302]}, {"key": "other-relatives", "type": "definition", "offset": [371, 386]}, {"key": "to-the-recipient", "type": "definition", "offset": [442, 458]}, {"key": "bone-marrow", "type": "clause", "offset": [507, 518]}], "hash": "d63d77299767c18f1da42aa9041ffe0d", "id": 6}, {"snippet": "means the use of cells or tissues derived, directly or indirectly, from any human subject other than the particular human subject to which such cells or tissues are administered or transplanted.", "samples": [{"hash": "6puO4ycnUNJ", "uri": "/contracts/6puO4ycnUNJ#allogeneic", "label": "Collaboration and Option Agreement (Fate Therapeutics Inc)", "score": 31.5927446954, "published": true}, {"hash": "6kq0Kqu928N", "uri": "https://ir.fatetherapeutics.com/static-files/3cec4d14-f79e-41ef-adf7-ae8ea68dffef", "label": "ir.fatetherapeutics.com", "score": 10.2963723477, "published": false}], "size": 2, "snippet_links": [{"key": "directly-or-indirectly", "type": "clause", "offset": [43, 65]}, {"key": "human-subject", "type": "definition", "offset": [76, 89]}, {"key": "subject-to", "type": "definition", "offset": [122, 132]}], "hash": "10e6b11f947860d02dfd9048a26d697d", "id": 7}, {"snippet": "(allogenic) means genetically dissimilar within the same species.", "samples": [{"hash": "92U2ME2Xu2B", "uri": "https://www.satiba.org.za/documents/resources/standards-for-blood-transfusion-v7.pdf", "label": "Amendment", "score": 12.4154688569, "published": false}], "size": 1, "snippet_links": [], "hash": "287ae0bafe3223e59258f0ccb014f6e3", "id": 8}, {"snippet": "means the collection of blood or blood components for subsequent transfusion to an individual other than the donor. The term \u201callogeneic\u201d is also known as homologous.", "samples": [{"hash": "1Y9SpJNAMJq", "uri": "https://www.state.nj.us/health/phel/documents/chapter8reg.pdf", "label": "www.state.nj.us", "score": 2.0, "published": false}], "size": 1, "snippet_links": [{"key": "blood-components", "type": "definition", "offset": [33, 49]}, {"key": "an-individual", "type": "clause", "offset": [80, 93]}, {"key": "the-term", "type": "definition", "offset": [116, 124]}], "hash": "57b1e150444762c861742209e1b73481", "id": 9}, {"snippet": "means, with respect to a Cell Therapy Product, that the [**].", "samples": [{"hash": "giRymWzr2Di", "uri": "/contracts/giRymWzr2Di#allogeneic", "label": "Collaboration Agreement (Immatics N.V.)", "score": 34.2183436003, "published": true}], "size": 1, "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "cell-therapy-product", "type": "definition", "offset": [25, 45]}], "hash": "c5a7c0e9bf32910749af94b15be0f586", "id": 10}], "next_curs": "ClcSUWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjMLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiITYWxsb2dlbmVpYyMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means transplantation between genetically non-identical individuals of the same species.", "size": 18, "title": "Allogeneic", "id": "allogeneic", "examples": ["Blood and Marrow Transplantation \u2013 <strong>Allogeneic</strong> Number St Vincent&#x27;s (38) Westmead (71) Royal \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 (26) Liverpool (18) \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 (\u2587\u2587+\u2587/\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587) \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 (26) SCHN Westmead (26) Provision of equitable access Blood and Marrow Transplant Laboratory Access St Vincent&#x27;s - to Gosford Westmead \u2013 to Nepean, Wollongong, SCHN Westmead Provision of equitable access Complex Epilepsy Access Westmead Royal Prince \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 of Wales SCHN Provision of equitable access.", "Service Code Service Name Measurement Unit Locations (Where applicable) Service Level Explanatory Notes Supra LHD Services BMTAA Blood and Marrow Transplantation \u2013 <strong>Allogeneic</strong> Number St Vincent&#x27;s (37) Westmead (62) Royal \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 (18) Liverpool (13) Royal North Shore (30) SCHN Randwick &amp; Westmead (51) See Locations Definition of Activity Measure: Number of transplants for listed patients.", "Blood and Marrow Transplantation \u2013 <strong>Allogeneic</strong> Number St Vincent&#x27;s (38) Westmead (71) Royal \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 (26) Liverpool (18) Royal North Shore (47) SCHN Randwick (26) SCHN Westmead (26) Provision of equitable access Blood and Marrow Transplant Laboratory Access St Vincent&#x27;s - to Gosford Westmead \u2013 to Nepean, Wollongong, SCHN Westmead Provision of equitable access.", "Without limiting the foregoing, the Parties shall discuss, at least annually through the JSC, whether Licensee intends to, or is continuing to pursue development or commercialization of an <strong>Allogeneic</strong> CTL Product for use in the Indications that are the subject of research and development activities pursuant to the Research Agreement.", "Upon completion of research activities under each Research Plan (other than the <strong>Allogeneic</strong> Cell Therapy Research Plan), Intrexon shall provide the JSC with a data package summarizing the data and results generated under such Research Plan with respect to the applicable Chimeric Antigen Receptor T-Cell Product.", "Promptly after, and in any event within thirty (30) days after, the Effective Date, ARES TRADING and Intrexon shall prepare a research plan for Intrexon\u2019s development of the <strong>Allogeneic</strong> Cell Therapy (the \u201c<strong>Allogeneic</strong> Cell Therapy Research Program\u201d) for submission to the JSC for review and approval.", "The Parties intend that once developed, the <strong>Allogeneic</strong> Cell Therapy will subsequently be used (in other Research Programs) to develop Chimeric Antigen Receptor T-Cell Products.", "Licensee will provide such information regarding its development and commercialization of such <strong>Allogeneic</strong> CTL Products as is required to reasonably inform Institute for the purposes of such discussions.", "Except for the <strong>Allogeneic</strong> Cell Therapy Research Plan, each Research Plan will describe the activities to be conducted to develop a Chimeric Antigen Receptor T-Cell Product directed to the applicable Target, through JSC approval of such Product as a drug candidate ready for the filing of an IND and Intrexon\u2019s delivery to ARES TRADING of information to be included in the IND for such Product.", "All decisions regarding the <strong>Allogeneic</strong> Cell Therapy Research Program and <strong>Allogeneic</strong> Cell Therapy Criteria shall be made by unanimous vote, with each of Merck\u2019s and Intrexon\u2019s representatives collectively having one (1) vote."], "related": [["bioassay", "Bioassay", "Bioassay"], ["biomarker", "Biomarker", "Biomarker"], ["vaccine", "Vaccine", "Vaccine"], ["hemp-product", "Hemp product", "Hemp product"], ["diagnostic-product", "Diagnostic Product", "Diagnostic Product"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}